Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

Developing new imaging approach for methionine aminopeptidase II for prostate cancer risk stratification

February 1, 2021

Exciting new results from our lab collaborative work reveal a new imaging approach for risk stratification of prostate cancer.

https://cancerres.aacrjournals.org/content/81/9/2510

February 1, 2021

NewsStanford

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousDr. Demirci and Dr. Stoyanova receive Spectrum MedTech Pilot Grant

  • NextNew review article on the role of Trop2 in prostate cancer

Related Posts ...

Exciting news: Dr. Hyeonji Hwang, a postdoctoral fellow at Dr. Stoyanova’s Lab in UCLA, awarded the Prostate Cancer Research Program Early Investigator Research Award by the US Department of Defense (DOD) for the project titled “Targeting Trop2-Mediated Ferroptosis as a New Therapy for Advanced Prostate Cancer”

News, UCLA

Exciting News: Dr. Tanya Stoyanova receives 2025 Neuroendocrine Tumor Research Foundation Pilot Award

News, UCLA

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login